Jan 2 2007
CDEX Inc. announced today that the US Patent and Trademark Office (USPTO) has issued patent number 7,154,102 to CDEX Inc. The patent relates to system and method for detection and identification of chemical substances.
Patent Abstract
The invention provides a system and method utilizing, among other things, fluorescence spectroscopy in the ultra-violet portion of the electromagnetic spectrum to determine chemical species and concentrations. The basic measuring system includes optics, a spectrograph, a detector, and an energy source ("head" components), along with a computer and control electronics and power source capable of generating and detecting unique fluorescence signatures for individual and unique mixtures of chemical substances including, for example, prescribed and/or compounded medications, alcohol products, food types, synthetic drugs, narcotics, perfumes, liquids, and the like.
"The issuance of this patent is a major milestone achievement for CDEX and affirms both our core technology and our approaches to applying it to a system and method that can be used to detect and identify chemical substances across multiple applications and settings," said Jim Griffin, CEO of CDEX Inc. "It will strengthen our ValiMed product offering and allow us to create future value for the company by applying this patent to the development of life safety products for the healthcare, security, and brand protection markets."